Schröder, L.; Mallmann, M.R.; Domroese, C.M.; Wefers, N.; Dolscheid-Pommerich, R.; Stoffel-Wagner, B.; Trulson, I.; Vahldiek, K.; Klawonn, F.; Holdenrieder, S.
Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms. Diagnostics 2023, 13, 3101.
https://doi.org/10.3390/diagnostics13193101
AMA Style
Schröder L, Mallmann MR, Domroese CM, Wefers N, Dolscheid-Pommerich R, Stoffel-Wagner B, Trulson I, Vahldiek K, Klawonn F, Holdenrieder S.
Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms. Diagnostics. 2023; 13(19):3101.
https://doi.org/10.3390/diagnostics13193101
Chicago/Turabian Style
Schröder, Lars, Michael R. Mallmann, Christian M. Domroese, Natalie Wefers, Ramona Dolscheid-Pommerich, Birgit Stoffel-Wagner, Inga Trulson, Kai Vahldiek, Frank Klawonn, and Stefan Holdenrieder.
2023. "Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms" Diagnostics 13, no. 19: 3101.
https://doi.org/10.3390/diagnostics13193101
APA Style
Schröder, L., Mallmann, M. R., Domroese, C. M., Wefers, N., Dolscheid-Pommerich, R., Stoffel-Wagner, B., Trulson, I., Vahldiek, K., Klawonn, F., & Holdenrieder, S.
(2023). Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms. Diagnostics, 13(19), 3101.
https://doi.org/10.3390/diagnostics13193101
